Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update

2 weeks ago

Ohtuvayre™ ( ensifentrine ) launch recorded Q3 net sales of $5.6 million and October net sales exceeded ...

Ticker	Sentiment	Impact
VRNA	Neutral	21 %